Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 37.74
-0.343 %
$ 2.08 B
Market Cap
35.27
P/E
SUPN - REVENUE
Revenue SUPN - Supernus Pharmaceuticals, Inc.
608 M
LAST VALUE
2.36%
2 YEAR CAGR
8.24%
5 YEAR CAGR
48.04%
10 YEAR CAGR